\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ examination\\:\\ normal\ \(0\)\
\-\ labs\\:\\ none\ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ multiple\\ bilateral\\ well\\ circumscribed\\ pulmonary\\ nodules\\,\\ without\\ spiculations\\ or\\ irregularities\\.\\ no\\ pathologic\\ lymphadenopathy\\.\ \(0\)\
\-\ benign\\ metastasizing\\ leiomyoma\ \(1\)\
\-\ metastatic\\ malignant\\ tumor\ \(0\)\
\-\ fungal\\ infection\ \(12\)\
\-\ granulomatous\\ diseases\ \(4\)\
\-\ much\\ less\\ likely\\:\\ metastatic\\ benign\\ tumor\\ \\(leiomyoma\\,\\ meningioma\\,\\ pleomorphic\\ adenoma\\,\\ giant\\ cell\\ tumor\\)\ \(0\)\
\-\ 48\\ year\\ old\\ female\\ presents\\ for\\ computed\\ tomography\\ after\\ notifying\\ her\\ primary\\ care\\ provider\\ that\\ years\\ earlier\\ she\\ was\\ told\\ she\\ had\\ a\\ nodule\\ in\\ her\\ lung\\ on\\ chest\\ x\\-ray\\.\ \(0\)\
\-\ surgical\\ history\\:\\ \ \(1\)\
\-\ cholecystectomy\\ at\\ age\\ 35\ \(0\)\
\-\ hysterectomy\\ at\\ age\\ 43\\ \\(for\\ fibroids\\)\ \(0\)\
\-\ benign\\ metastasizing\\ leiomyoma\\ is\\ an\\ extremely\\ rare\\ disorder\\,\\ occuring\\ almost\\ exclusively\\ in\\ women\\ \\(20\\+\\ years\\ of\\ age\\)\\,\\ most\\ of\\ whom\\ have\\ a\\ history\\ of\\ uterine\\ leiomyoma\\ resection\\ or\\ hysterecomy\\ due\\ to\\ large\\ leimyomata\\.\\ lesions\\ which\\ metastasize\\ to\\ the\\ lung\\ may\\ be\\ solitary\\ or\\ multiple\\,\\ appear\\ as\\ well\\ circumscribed\\ rounded\\ lesions\\,\\ and\\ cannot\\ be\\ distinguished\\ from\\ other\\ causes\\ of\\ pulmonary\\ nodules\\ without\\ tissue\\ sampling\\.\\ \ \(0\)\
\-\ patients\\ are\\ usually\\ asymptomatic\\.\\ lesions\\ behave\\ as\\ slow\\ growing\\ benign\\ tumors\\ but\\ some\\ reports\\ refer\\ to\\ them\\ as\\ a\\ low\\ grade\\ sarcoma\\,\\ particularly\\ when\\ found\\ in\\ children\\.\\ lesions\\ are\\ generally\\ quite\\ hormone\\ sensitive\\,\\ though\\ again\\ less\\ so\\ in\\ children\\.\\ \ \(0\)\
\-\ \\ \ \(1082074\)\
\-\ reference\\(s\\)\\:\ \(0\)\
\-\ armstrong\\ p\\.\\ et\\ al\\.\\ imaging\\ of\\ diseases\\ of\\ the\\ chest\\ 3rd\\ edition\\.\\ mosby\\ 2000\\:351\\ \ \(0\)\
\-\ galvin\\ jr\\.\\ et\\ al\\.\\ benign\\ metastasizing\\ leiomyoma\\.\\ the\\ international\\ thoracic\\ teaching\\ resource\\:\\ neoplastic\\ diseases\\.http\\:\\/\\/www\\.vh\\.org\\/adult\\/provider\\/radiology\\/ittr\\/benignmetaleiomyoma\\/bngmetaleiomyoma\\.html\\ \ \(0\)\
\-\ joon\\ beom\\ seo\\.\\ et\\ al\\.\\ atypical\\ pulmonary\\ metastases\\:\\ spectrum\\ of\\ radiologic\\ findings\\.\\ radiographics\\.\\ 2001\\;21\\:403\\-417\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ leiomyoma\\:\\ 0\\.3266254721577465\ \(0\)\
\-\ metastasizing\\:\\ 0\\.27148205623236715\ \(0\)\
\-\ benign\\:\\ 0\\.21605660089933948\ \(0\)\
\-\ diseases\\:\\ 0\\.17338359494772945\ \(0\)\
\-\ al\\:\\ 0\\.1499449277218922\ \(0\)\
\-\ et\\:\\ 0\\.14783083417814477\ \(0\)\
\-\ lesions\\:\\ 0\\.14450765473736865\ \(0\)\
\-\ provider\\:\\ 0\\.13744976253252814\ \(0\)\
\-\ age\\:\\ 0\\.11847668156449885\ \(0\)\
\-\ pulmonary\\:\\ 0\\.11503004230311616\ \(0\)\
\-\ children\\:\\ 0\\.1030849477619897\ \(0\)\
\-\ notifying\\:\\ 0\\.10059839574228999\ \(0\)\
\-\ hysterecomy\\:\\ 0\\.10059839574228999\ \(0\)\
\-\ leimyomata\\:\\ 0\\.10059839574228999\ \(0\)\
\-\ galvin\\:\\ 0\\.10059839574228999\ \(0\)\
\-\ beom\\:\\ 0\\.10059839574228999\ \(0\)\
\-\ seo\\:\\ 0\\.10059839574228999\ \(0\)\
\-\ nodules\\:\\ 0\\.09996328514792813\ \(0\)\
\-\ tumor\\:\\ 0\\.09870850782986403\ \(0\)\
\-\ circumscribed\\:\\ 0\\.09742786978273514\ \(0\)\
\-\ spiculations\\:\\ 0\\.09612713769131326\ \(0\)\
\-\ joon\\:\\ 0\\.09612713769131326\ \(0\)\
\-\ behave\\:\\ 0\\.09295472961759917\ \(0\)\
\-\ resource\\:\\ 0\\.09295472961759917\ \(0\)\
\-\ armstrong\\:\\ 0\\.08848347156662244\ \(0\)\
\-\ of\\:\\ 0\\.08617127323247228\ \(0\)\
\-\ less\\:\\ 0\\.08559027899514315\ \(0\)\
\-\ whom\\:\\ 0\\.08285035261943156\ \(0\)\
\-\ sampling\\:\\ 0\\.07995713614696529\ \(0\)\
\-\ teaching\\:\\ 0\\.07995713614696529\ \(0\)\
\-\ occuring\\:\\ 0\\.07913991202457424\ \(0\)\
\-\ her\\:\\ 0\\.07859864351611252\ \(0\)\
\-\ years\\:\\ 0\\.07711954469888047\ \(0\)\
\-\ metastasize\\:\\ 0\\.0769988606113831\ \(0\)\
\-\ lung\\:\\ 0\\.07653137761822632\ \(0\)\
\-\ international\\:\\ 0\\.07636854739095487\ \(0\)\
\-\ as\\:\\ 0\\.07581321635363134\ \(0\)\
\-\ irregularities\\:\\ 0\\.07577232223232996\ \(0\)\
\-\ she\\:\\ 0\\.07489140250750259\ \(0\)\
\-\ exclusively\\:\\ 0\\.07466865397359751\ \(0\)\
\-\ told\\:\\ 0\\.07415565546822775\ \(0\)\
\-\ distinguished\\:\\ 0\\.07415565546822775\ \(0\)\
\-\ hysterectomy\\:\\ 0\\.07319613931724078\ \(0\)\
\-\ jr\\:\\ 0\\.07231347002227446\ \(0\)\
\-\ fibroids\\:\\ 0\\.07110927710013237\ \(0\)\
\-\ refer\\:\\ 0\\.070735428443764\ \(0\)\
\-\ metastatic\\:\\ 0\\.06900022140664863\ \(0\)\
\-\ them\\:\\ 0\\.06842273964796622\ \(0\)\
\-\ quite\\:\\ 0\\.06756302037004992\ \(0\)\
\-\ edition\\:\\ 0\\.06676550577786063\ \(0\)\
\-\ chest\\:\\ 0\\.06640863339851817\ \(0\)\
\-\ without\\:\\ 0\\.06635978518713274\ \(0\)\
\-\ or\\:\\ 0\\.06565033123040866\ \(0\)\
\-\ mosby\\:\\ 0\\.06532509443154931\ \(0\)\
\-\ extremely\\:\\ 0\\.06445975032351242\ \(0\)\
\-\ hormone\\:\\ 0\\.06405127847006013\ \(0\)\
\-\ spectrum\\:\\ 0\\.0638525797751926\ \(0\)\
\-\ pleomorphic\\:\\ 0\\.06365739805666241\ \(0\)\
\-\ radiographics\\:\\ 0\\.06346561097544155\ \(0\)\
\-\ in\\:\\ 0\\.06259464491644721\ \(0\)\
\-\ sensitive\\:\\ 0\\.06187490141252556\ \(0\)\
\-\ growing\\:\\ 0\\.06171152836200145\ \(0\)\
\-\ reference\\:\\ 0\\.06155054040486012\ \(0\)\
\-\ multiple\\:\\ 0\\.06153616829414084\ \(0\)\
\-\ cholecystectomy\\:\\ 0\\.06108121514157324\ \(0\)\
\-\ tomography\\:\\ 0\\.060929109568490306\ \(0\)\
\-\ well\\:\\ 0\\.060917583776319124\ \(0\)\
\-\ computed\\:\\ 0\\.0606310514455964\ \(0\)\
\-\ slow\\:\\ 0\\.0606310514455964\ \(0\)\
\-\ particularly\\:\\ 0\\.059381321724215855\ \(0\)\
\-\ 2001\\:\\ 0\\.059381321724215855\ \(0\)\
\-\ 43\\:\\ 0\\.058868323218846094\ \(0\)\
\-\ uterine\\:\\ 0\\.05874371760817508\ \(0\)\
\-\ radiologic\\:\\ 0\\.05862050426809646\ \(0\)\
\-\ neoplastic\\:\\ 0\\.058140973100136335\ \(0\)\
\-\ solitary\\:\\ 0\\.05756947324158345\ \(0\)\
\-\ earlier\\:\\ 0\\.057458643371882306\ \(0\)\
\-\ 3rd\\:\\ 0\\.057458643371882306\ \(0\)\
\-\ rounded\\:\\ 0\\.057240270311024716\ \(0\)\
\-\ women\\:\\ 0\\.056609957090596505\ \(0\)\
\-\ almost\\:\\ 0\\.05650832061801999\ \(0\)\
\-\ fungal\\:\\ 0\\.056307815472298656\ \(0\)\
\-\ giant\\:\\ 0\\.05611089096763884\ \(0\)\
\-\ again\\:\\ 0\\.05611089096763884\ \(0\)\
\-\ granulomatous\\:\\ 0\\.055917421457669245\ \(0\)\
\-\ though\\:\\ 0\\.054650581602193084\ \(0\)\
\-\ much\\:\\ 0\\.05448092472950775\ \(0\)\
\-\ 48\\:\\ 0\\.05448092472950775\ \(0\)\
\-\ generally\\:\\ 0\\.053285443443799485\ \(0\)\
\-\ disorder\\:\\ 0\\.05321017025588175\ \(0\)\
\-\ so\\:\\ 0\\.05291411276420021\ \(0\)\
\-\ sarcoma\\:\\ 0\\.05276901226004798\ \(0\)\
\-\ atypical\\:\\ 0\\.05160715136383384\ \(0\)\
\-\ pathologic\\:\\ 0\\.05154247388099485\ \(0\)\
\-\ be\\:\\ 0\\.05103588764876001\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.050854986304558716\ \(0\)\
\-\ metastases\\:\\ 0\\.050854986304558716\ \(0\)\
\-\ 35\\:\\ 0\\.0504388056222624\ \(0\)\
\-\ adenoma\\:\\ 0\\.05015086552455232\ \(0\)\
\-\ nodule\\:\\ 0\\.04965079338241663\ \(0\)\
\-\ appear\\:\\ 0\\.04954267997515373\ \(0\)\
\-\ reports\\:\\ 0\\.048915355636492644\ \(0\)\
\-\ history\\:\\ 0\\.04806651511235599\ \(0\)\
\-\ are\\:\\ 0\\.04773898635718345\ \(0\)\
\-\ causes\\:\\ 0\\.04753213279765378\ \(0\)\
\-\ at\\:\\ 0\\.04751984373241806\ \(0\)\
\-\ rare\\:\\ 0\\.04748739651231444\ \(0\)\
\-\ to\\:\\ 0\\.04717819466376104\ \(0\)\
\-\ meningioma\\:\\ 0\\.047135893312857106\ \(0\)\
\-\ thoracic\\:\\ 0\\.047006915477502256\ \(0\)\
\-\ tumors\\:\\ 0\\.04626320815547847\ \(0\)\
\-\ grade\\:\\ 0\\.04523399212957591\ \(0\)\
\-\ care\\:\\ 0\\.0449466148450036\ \(0\)\
\-\ malignant\\:\\ 0\\.04484075023152026\ \(0\)\
\-\ labs\\:\\ 0\\.043580990969464446\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.04282435138011686\ \(0\)\
\-\ found\\:\\ 0\\.04070224309196113\ \(0\)\
\-\ resection\\:\\ 0\\.04032276550379838\ \(0\)\
\-\ examination\\:\\ 0\\.040253044644285696\ \(0\)\
\-\ usually\\:\\ 0\\.03960087318238504\ \(0\)\
\-\ some\\:\\ 0\\.039579058181774596\ \(0\)\
\-\ primary\\:\\ 0\\.03867963743407723\ \(0\)\
\-\ for\\:\\ 0\\.03813189621015223\ \(0\)\
\-\ infection\\:\\ 0\\.03799811119441785\ \(0\)\
\-\ when\\:\\ 0\\.03799811119441785\ \(0\)\
\-\ the\\:\\ 0\\.0376553331523884\ \(0\)\
\-\ likely\\:\\ 0\\.03759032600488509\ \(0\)\
\-\ due\\:\\ 0\\.03615883115731087\ \(0\)\
\-\ low\\:\\ 0\\.03609508832542063\ \(0\)\
\-\ cell\\:\\ 0\\.03598441735425928\ \(0\)\
\-\ patients\\:\\ 0\\.03538736427572614\ \(0\)\
\-\ none\\:\\ 0\\.03437705014179378\ \(0\)\
\-\ physical\\:\\ 0\\.03410840155220754\ \(0\)\
\-\ bilateral\\:\\ 0\\.033807335943005765\ \(0\)\
\-\ imaging\\:\\ 0\\.033058576967270305\ \(0\)\
\-\ tissue\\:\\ 0\\.03299841599311195\ \(0\)\
\-\ most\\:\\ 0\\.03273753872738643\ \(0\)\
\-\ other\\:\\ 0\\.032667448581180376\ \(0\)\
\-\ may\\:\\ 0\\.031655655633365434\ \(0\)\
\-\ large\\:\\ 0\\.03151840423998656\ \(0\)\
\-\ have\\:\\ 0\\.03142437495127236\ \(0\)\
\-\ had\\:\\ 0\\.031341461183125884\ \(0\)\
\-\ but\\:\\ 0\\.031106499055032814\ \(0\)\
\-\ findings\\:\\ 0\\.031046019127131497\ \(0\)\
\-\ surgical\\:\\ 0\\.0305737623044978\ \(0\)\
\-\ after\\:\\ 0\\.030516127264525413\ \(0\)\
\-\ female\\:\\ 0\\.030354445069727023\ \(0\)\
\-\ presents\\:\\ 0\\.03026043359486672\ \(0\)\
\-\ which\\:\\ 0\\.028603417428951616\ \(0\)\
\-\ that\\:\\ 0\\.027298304126072415\ \(0\)\
\-\ normal\\:\\ 0\\.025683589185783486\ \(0\)\
\-\ from\\:\\ 0\\.024983101327619918\ \(0\)\
\-\ an\\:\\ 0\\.02405456670138327\ \(0\)\
\-\ was\\:\\ 0\\.02192292948802882\ \(0\)\
\-\ no\\:\\ 0\\.020455910162035643\ \(0\)\
\-\ year\\:\\ 0\\.019386006634562112\ \(0\)\
\-\ on\\:\\ 0\\.01899831539254108\ \(0\)\
\-\ old\\:\\ 0\\.018617277001911105\ \(0\)\
\-\ is\\:\\ 0\\.01722689420540954\ \(0\)\
\-\ and\\:\\ 0\\.012998497234154823\ \(0\)\
\-\ can\\:\\ 0\\.0\ \(0\)\
\-\ not\\:\\ 0\\.0\ \(0\)\
